Literature DB >> 7878530

Effect of growth hormone and protein intake on tumor growth and host cachexia.

D L Bartlett1, T P Stein, M H Torosian.   

Abstract

BACKGROUND: Growth hormone supplementation has been shown to stimulate muscle protein synthesis and to improve nitrogen balance in a variety of catabolic states. The role of growth hormone to support the tumor-bearing host is complicated by the risk that growth hormone or its intermediaries may stimulate tumor growth. The purpose of this study is to examine the effect of growth hormone supplementation in tumor-bearing rats. This is studied in the protein-fed and protein-starved state in an attempt to isolate a selective benefit for the host over the tumor.
METHODS: Forty Lewis rats bearing a metastatic mammary adenocarcinoma (MAC-33) were divided into four groups: one receiving a regular diet plus saline solution, one receiving a regular diet plus growth hormone (1 IU/kg/day), one receiving protein-depleted diet plus saline solution, and one receiving a protein-depleted diet plus growth hormone. After 25 days of growth hormone treatment, animals were killed to determine primary tumor size, tumor/carcass ratio, host organ composition, pulmonary metastasis, and serum amino acid levels.
RESULTS: The tumor/carcass ratio was decreased as a result of growth hormone treatment in both the protein-fed and protein-starved groups. Growth hormone supplementation resulted in increased carcass weight, muscle weight, and muscle protein content in the protein-fed, tumor-bearing animals (p < 0.05). In the protein-starved, tumor-bearing rats growth hormone supplementation resulted in a significant decrease in tumor volume and tumor protein content. Amino acid analysis suggests that the amino acid tyrosine is a rate-limiting substrate for tumor cell proliferation in this model.
CONCLUSIONS: Growth hormone has a differential effect on tumor and host growth in the protein-fed and protein-starved state. Growth hormone supplementation inhibited tumor growth in protein-deprived animals. This is most likely accomplished indirectly by limiting amino acid substrate availability to the tumor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7878530     DOI: 10.1016/s0039-6060(05)80199-0

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

1.  Effects of recombinant human growth hormone on growth of human gastric carcinoma xenograft model in nude mice.

Authors:  Dao-Ming Liang; Jia-Yong Chen; Yi Zhang; Ping Gan; Jie Lin; An-Bao Chen
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

2.  Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.

Authors:  José M Garcia; John Friend; Suzan Allen
Journal:  Support Care Cancer       Date:  2012-06-16       Impact factor: 3.603

3.  Effects of parenteral nutrition with and without GH on the GH/IGF-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis.

Authors:  Jie Cao; Shimin Luo; Lijian Liang; Jiaming Lai; Shanming Chen
Journal:  Front Med China       Date:  2007-07-01

4.  Differential action of growth hormone in irradiated tumoral and nontumoral intestinal tissue.

Authors:  Juana Morante; María T Vallejo-Cremades; Lourdes Gómez-García; Isabel Vázquez; Ignacio A Gómez-de-Segura; Miriam Sanchez; Enrique De Miguel
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

5.  In vitro effects of recombinant human growth hormone on growth of human gastric cancer cell line BGC823 cells.

Authors:  Jia-Yong Chen; Dao-Ming Liang; Ping Gan; Yi Zhang; Jie Lin
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.